Publications by authors named "Vijay Mehra"

Claim this Profile
S
Safety and immunogenicity of a polyvalent DNA-protein HIV vaccine with matched Env immunogens delivered as a prime-boost regimen or coadministered in HIV-uninfected adults in the USA (HVTN 124): a phase 1, placebo-controlled, double-blind randomised controlled trial.
Ian Frank, Shuying S Li, Nicole Grunenberg, Edgar T Overton, Samuel T Robinson, Vijay L Mehra

Lancet HIV· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing the Immunogenicity of HIV Vaccines by Adjuvants - NIAID Workshop Report.
Anjali Singh, César Boggiano, Michael A Eller, Milton Maciel, Mary A Marovich, Vijay L Mehra

Vaccine· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymptomatic Blue-Green Bumps on Skin Inherited from Father to Daughter in an Indian Family.
Shruti Sharma, Surabhi Dayal, Nisha Marwah, Komal Brar, Kamal Aggarwal, Vijay Kumar Mehra

Skin Appendage Disord· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HIV-1 Vaccine Sequences Impact V1V2 Antibody Responses: A Comparison of Two Poxvirus Prime gp120 Boost Vaccine Regimens.
Xiaoying Shen, Fatima Laher, Zoe Moodie, Arthur S McMillan, Rachel L Spreng, Vijay L Mehra

Sci Rep· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and immune responses after a 12-month booster in healthy HIV-uninfected adults in HVTN 100 in South Africa: A randomized double-blind placebo-controlled trial of ALVAC-HIV (vCP2438) and bivalent subtype C gp120/MF59 vaccines.
Fatima Laher, Zoe Moodie, Kristen W Cohen, Nicole Grunenberg, Linda-Gail Bekker, Vijay L Mehra

PLoS Med· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial.
Linda-Gail Bekker, Zoe Moodie, Nicole Grunenberg, Fatima Laher, Georgia D Tomaras, Vijay L Mehra

Lancet HIV· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Now that you want to take your HIV/AIDS vaccine/biological product research concept into the clinic: what are the "cGMP"?
Rebecca L Sheets, Vijaya Rangavajhula, Jeffrey K Pullen, Chris Butler, Vijay Mehra

Vaccine· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mucosal immunity and HIV/AIDS vaccines. Report of an International Workshop, 28-30 October 2007.
Marc P Girard, Geetha P Bansal, Livia Pedroza-Martins, Betty Dodet, Vijay Mehra

Vaccine· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis